MOBILion Systems, Chadds Ford, Pa.-based instrumentation company for biomarker discovery, diagnostics and therapeutic development, raised $35 million in Series B funding. aMoon led the round and was joined by investors including Agilent Technologies (NYSE: A), IP Group, Hostplus, and Cultivation Capital.